MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)

NCT00837577 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Non-Insulin-Dependent

Interventions

DRUG: Comparator: Placebo
DRUG: Sitagliptin
DRUG: Voglibose

Sponsor

Merck Sharp & Dohme LLC